SENSEX
NIFTY
GOLD
USD/INR

Weather

image 34    C

Business News

The Hindu Businessline

Business / The Hindu Businessline

details

Biocon sees stronger H2 on US biosimilar launches, regulatory easing

The US regulators decision to move away from subjecting companies to undertake mandatory efficacy trials in phase-3 bodes well for incumbents such as Biocon

6 Aug 2026 7:24 pm